Clinical trial
SJG-136 in Treating Patients With Advanced Solid Tumors
NCT00103220 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00103220 |
|---|---|
| Title | SJG-136 in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Study With SJG-136 (NSC #694501) in Patients With an Advanced Solid Tumor |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | SJG-136 |
| Enrollment | 36 |
| Start date | Nov 1, 2004 |
| Primary completion | Feb 1, 2007 |
| First posted | Feb 8, 2005 |
| Last update posted | Dec 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: